SMARCAL1 and Schimke immuno-osseous dysplasia: Although we did not observe changes in cholesterol levels in the SmarcAL1 KO mice (see Discussion), the downregulation of LDLR expression aligns with the hypercholesterolemia observed in SIOD patients.